Rchr
J-GLOBAL ID:200901082194284300
Update date: Oct. 21, 2024
ITO TOMOKI
イトウ トモキ | ITO TOMOKI
Affiliation and department:
Job title:
Professor
Research field (2):
Allergies and connective tissue disease
, Immunology
Research theme for competitive and other funds (10):
- 2018 - 2020 Functional analysis of OX40 signal in glioma cancer stem cells
- 2012 - 2015 線溶系物質による樹状細胞機能の制御:炎症性疾患に向けた新たな治療コンセプトの提案
- 2011 - 2014 血管内皮細胞由来マイクロパーティクルによるDIC病態早期診断法の研究
- 2011 - 現在 全身性エリテマトーデスにおける樹状細胞機能に及ぼすプロラクチンの作用について
- 2009 - 2011 Trial to the therapeutic strategy for inflammatory disorders by targeting immunomodulatory molecule OX40 ligand
- 2009 - 2010 I型インターフェロン制御を目的としたトロンボモジュリンの抗炎症作用機序の解明
- 2010 - I型インターフェロン制御を目的としたトロンボモジュリンの新たな抗免疫作用機序の解明
- 2008 - 2009 Imidazoquinolineを用いたアレルギー性疾患治療療法の開発
- 2009 - 2010 I型インターフェロン制御を目的としたトロンボモジュリンの抗炎症作用機序の解明
- 2007 - Imidazoquinolineを用いたアレルギー性免疫応答における樹状細胞制御及び機能変換の解析
Show all
Papers (154):
-
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Aspiration pneumonia after SARS-CoV-2 Omicron infection frequently induced physical functional decline in Japan. Journal of medical microbiology. 2024. 73. 8. 001872
-
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Ito T. Invalidity of JRS atypical pneumonia prediction score in Omicron variant of COVID-19 pneumonia. Respiratory investigation. 2024. 62. 3. 384-387
-
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Comparison of pneumonia severity scores for COVID-19 patients with the Omicron variant. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024. 30. 5. 463-466
-
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Ito T. Is the JRS atypical pneumonia prediction score useful in detecting COVID-19 pneumonia under nursing or healthcare settings?. Respiratory investigation. 2024. 62. 2. 187-191
-
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Functional decline at 1 year in hospitalized elderly pneumonia with SARS-CoV-2 Omicron variant: Comparison with the ancestral strain and Alpha variant. Influenza and other respiratory viruses. 2024. 18. 2. e13251
more...
MISC (77):
-
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Efficacy of ensitrelvir for cough due to COVID-19 Omicron variant in medical healthcare workers. Antimicrobial agents and chemotherapy. 2024. 68. 10. e0106424
-
Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Aspiration pneumonia was the most frequent cause of death in older patients with SARS-CoV-2 omicron-related pneumonia in Japan. Journal of the American Geriatrics Society. 2024. 72. 7. 2234-2236
-
Yuka Ishii, Jun Ichikawa, Masaya Okada, Kazuyoshi Ishii and Tomoki Ito. Successful treatment of Dara sc-CyBorD in a patient with AL amiyloidosis and severe heart failure. International Journal of Myeloma 14(1):5-11,2024. 2024. 14. 1. 5-11
-
Kuwana M, Ito T, Kowata S, Hatta Y, Fujimaki K, Naito K, Kurahashi S, Kagoo T, Tanimoto K, Saotome S, et al. Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study. American journal of hematology. 2024. 99. 2. E55-E59
-
Ishiura Y, Nomura S, Ishii Y, Imai K, Sawai Y, Tamaki T, Shimizu T, Miyashita N, Ito T. Efficacy of Gefapixant, a P2X3 Antagonist, for Refractory Atopic Cough. International medical case reports journal. 2023. 16. 4. 497-501
more...
Books (9):
-
B 細胞リンパ腫に対する BCL-2 阻害薬「血液内科」
科学評論社 2023
-
プロテアソーム阻害薬「臨床雑誌内科」
南江堂 2022
-
エロツズマブと血小板減少「Thrombosis Medicine」
先端医学社 2020
-
悪性リンパ腫におけるFDG-PETと背景抑制広範囲拡散強調画像(DWIBS)を用いた評価の試み「臨床放射線」
金原出版 2020
-
多発性骨髄腫における抗体医薬エロツズマブ・ダラツムマブの作用機序および治療選択「血液内科」
科学評論社 2020
more...
Lectures and oral presentations (346):
-
Phase 1/2 Study of the Activin Receptor-like Kinase-2 Inhibitor Zilurgisertib (INCB000928, LIMBER-104) as Monotherapy or With Ruxolitinib in Patients With Anemia due to Myelofibrosis
(ASH2023 第65回米国血液学会 2023)
-
LONG-TERM TREATMENT WITH FOSTAMATINIB IN JAPANESE PATIENTS WITH PRIMARY ITP
(ASH2023 第66回米国血液学会 2023)
-
Interim Phase I Safety Study of Anti-Transferrin Receptor Antibody(PPMX-T003) in Patients with Polycythemia Vera
(ASH2023 第65回米国血液学会 2023)
-
Thrombotic and bleeding events in Japanese Adolescent and Young Adult PV and ET - Results from Japanese multicenter retrospective study -
(ASH2023 第65回米国血液学会 2023)
-
Efficacy and Safety of Polatuzumab-Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) for Diffuse Large B-Cell Lymphoma in the Real-World Setting: A Single Institute Retrospective Study
(65th American Society of Hematology Annual Meeting and Exposition 2023)
more...
Work history (1):
- 2007/04 - 2011/04 Kansai Medical University Faculty of Medicine Lecturer
Committee career (5):
- 2000 - 現在 日本リンパ網内系学会 評議員
- 1994 - 現在 日本リンパ網内系学会 将来構想委員
- 日本臨床血液学会 代議員
- 日本免疫学会 評議員
- 日本血液学会 代議員
Awards (1):
- 1999 - 第39回日本リンパ網内系学会総会学会奨励賞(臨床部門)
Association Membership(s) (5):
日本リウマチ学会
, 日本免疫学会
, 日本臨床血液学会
, 日本リンパ網内系学会
, 日本血液学会
Return to Previous Page